159 related articles for article (PubMed ID: 31027051)
21. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
Bensoussan A; Kellow JE; Bourchier SJ; Fahey P; Shim L; Malcolm A; Boyce P
Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1946-54.e1. PubMed ID: 26133902
[TBL] [Abstract][Full Text] [Related]
22. Effect of inulin and fructo-oligosaccharide on the prevention of acute radiation enteritis in patients with gynecological cancer and impact on quality-of-life: a randomized, double-blind, placebo-controlled trial.
Garcia-Peris P; Velasco C; Hernandez M; Lozano MA; Paron L; de la Cuerda C; Breton I; Camblor M; Guarner F
Eur J Clin Nutr; 2016 Feb; 70(2):170-4. PubMed ID: 26603881
[TBL] [Abstract][Full Text] [Related]
23. The effect of faecal microbiota transplantation on abdominal pain, stool frequency, and stool form in patients with moderate-to-severe irritable bowel syndrome: results from a randomised, double-blind, placebo-controlled study.
Madsen AMA; Halkjær SI; Christensen AH; Günther S; Browne PD; Kallemose T; Hansen LH; Petersen AM
Scand J Gastroenterol; 2021 Jul; 56(7):761-769. PubMed ID: 34000958
[TBL] [Abstract][Full Text] [Related]
24. A poly-herbal blend (Herbagut®) on adults presenting with gastrointestinal complaints: a randomised, double-blind, placebo-controlled study.
Lopresti AL; Gupta H; Smith SJ
BMC Complement Altern Med; 2018 Mar; 18(1):98. PubMed ID: 29554961
[TBL] [Abstract][Full Text] [Related]
25. Effect of Ubiquinol Intake on Defecation Frequency and Stool Form: A Prospective, Double-Blinded, Randomized Control Study.
Suzuki S; Gotoda T; Kusano C; Ikehara H; Miyakoshi Y; Fujii K
J Med Food; 2019 Jan; 22(1):81-86. PubMed ID: 30192695
[TBL] [Abstract][Full Text] [Related]
26. Effect of oral naloxone on opioid-induced constipation in methadone maintenance treatment patients, a double-blind, placebo-control, clinical trial.
Akhgarandouz S; Moshiri M; Etemad L; Dadpour B; Khadem-Rezaiyan M; Vahdati-Mashhadian N
Ir J Med Sci; 2024 Mar; ():. PubMed ID: 38502432
[TBL] [Abstract][Full Text] [Related]
27. Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
Schoenfeld P; Lacy BE; Chey WD; Lembo AJ; Kurtz CB; Reasner DS; Bochenek W; Tripp K; Currie MG; Fox SM; Blakesley RE; OʼDea CR; Omniewski ND; Hall ML
Am J Gastroenterol; 2018 Jan; 113(1):105-114. PubMed ID: 29091082
[TBL] [Abstract][Full Text] [Related]
28. A high-fibre personalised dietary advice given via a web tool reduces constipation complaints in adults.
Rijnaarts I; de Roos NM; Wang T; Zoetendal EG; Top J; Timmer M; Hogenelst K; Bouwman EP; Witteman B; de Wit N
J Nutr Sci; 2022; 11():e31. PubMed ID: 35573462
[TBL] [Abstract][Full Text] [Related]
29. Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Benefit of the Probiotic Bifidobacterium infantis 35624 in Non-Patients With Symptoms of Abdominal Discomfort and Bloating.
Ringel-Kulka T; McRorie J; Ringel Y
Am J Gastroenterol; 2017 Jan; 112(1):145-151. PubMed ID: 27845337
[TBL] [Abstract][Full Text] [Related]
30. Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions.
Yang Y; Fang J; Guo X; Dai N; Shen X; Yang Y; Sun J; Bhandari BR; Reasner DS; Cronin JA; Currie MG; Johnston JM; Zeng P; Montreewasuwat N; Chen GZ; Lim S
J Gastroenterol Hepatol; 2018 May; 33(5):980-989. PubMed ID: 29319191
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.
Nakajima A; Seki M; Taniguchi S; Ohta A; Gillberg PG; Mattsson JP; Camilleri M
Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):537-547. PubMed ID: 29805116
[TBL] [Abstract][Full Text] [Related]
32. Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial.
Lacy BE; Schey R; Shiff SJ; Lavins BJ; Fox SM; Jia XD; Blakesley RE; Hao X; Cronin JA; Currie MG; Kurtz CB; Johnston JM; Lembo AJ
PLoS One; 2015; 10(7):e0134349. PubMed ID: 26222318
[TBL] [Abstract][Full Text] [Related]
33. Effects of Polydextrose Supplementation on Intestinal Function in Hemodialysis Patients: A Double-Blind, Randomized, Placebo-Controlled Trial.
Borges NA; Sahiun E; Ribeiro-Alves M; Regis B; Mafra D
J Ren Nutr; 2023 Nov; 33(6):747-754. PubMed ID: 37321430
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation.
Sloots CE; Rykx A; Cools M; Kerstens R; De Pauw M
Dig Dis Sci; 2010 Oct; 55(10):2912-21. PubMed ID: 20428949
[TBL] [Abstract][Full Text] [Related]
35. Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride.
Tack J; Camilleri M; Dubois D; Vandeplassche L; Joseph A; Kerstens R
Neurogastroenterol Motil; 2015 Mar; 27(3):397-405. PubMed ID: 25581251
[TBL] [Abstract][Full Text] [Related]
36.
Mourey F; Decherf A; Jeanne JF; Clément-Ziza M; Grisoni ML; Machuron F; Legrain-Raspaud S; Bourreille A; Desreumaux P
World J Gastroenterol; 2022 Jun; 28(22):2509-2522. PubMed ID: 35979259
[TBL] [Abstract][Full Text] [Related]
37. Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double-blind, placebo-controlled study.
Fukudo S; Nakajima A; Fujiyama Y; Kosako M; Nakagawa A; Akiho H; Nakashima Y; Johnston JM; Miwa H
Neurogastroenterol Motil; 2018 May; 30(5):e13275. PubMed ID: 29278278
[TBL] [Abstract][Full Text] [Related]
38. A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome.
Pineton de Chambrun G; Neut C; Chau A; Cazaubiel M; Pelerin F; Justen P; Desreumaux P
Dig Liver Dis; 2015 Feb; 47(2):119-24. PubMed ID: 25488056
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of Bacillus clausii in Pediatric Functional Constipation: A Pilot of a Randomized, Double-Blind, Placebo-Controlled Trial.
Lojanatorn P; Phrommas J; Tanpowpong P; Getsuwan S; Lertudomphonwanit C; Treepongkaruna S
Indian Pediatr; 2023 Jun; 60(6):453-458. PubMed ID: 36757002
[TBL] [Abstract][Full Text] [Related]
40. Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials.
Brenner DM; Fogel R; Dorn SD; Krause R; Eng P; Kirshoff R; Nguyen A; Crozier RA; Magnus L; Griffin PH
Am J Gastroenterol; 2018 May; 113(5):735-745. PubMed ID: 29545635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
